From microglia reprogramming to immune cell-based diagnostics, 2025 was a big year for breakthroughs in cell biology.

A notice from an ophthalmologist in Japan, announcing a temporary closure of their clinic to attend the Nobel Prize ceremony ...

Qihan's QT-019B program is supported by IND clearance for rSLE from both the US FDA and the China NMPA. The FDA has also granted Fast Track Designation for the SLE-ITP indication. Phase 1 enrollment ...

Early-life RSV infection and parental allergy interact to substantially increase childhood asthma risk, supported by ...

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the presentation of new preclinical data on ...

By Priyanjana Pramanik, MSc. Even when immune memory cells form in the lung after influenza infection, insufficient dietary ...

It’s about co-creating science.” The event highlighted pathogen research discoveries and pandemic prevention efforts from ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

The University of Osaka and Kyoto University have established funds to support the research fields of Nobel laureates Shimon ...

A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may ...

The axolotl, a type of salamander that stays in the tadpole form throughout its life, is a master of regeneration. Axolotls ...

Interdisciplinary scientist brings expertise in molecular biology and bioinformatics to study HIV reservoir, where dormant ...